Article citationsMore >>

Rubio-Tapia A, Murray JA. Classification and Management of refractory celiac disease. Gut 2010; 59:547-57.

has been cited by the following article:

Article

Complete Resolution of Type 1 Refractory Celiac Disease after Combined Treatment with Budesonide and Azathioprine: A Case Report and Literature Review

1Gastroenterology Section, Internal Medicine Department, Centro de Educación Médica e Investigación Clínica (CEMIC), Buenos Aires, Argentina


International Journal of Celiac Disease. 2015, Vol. 3 No. 1, 40-43
DOI: 10.12691/ijcd-3-1-3
Copyright © 2015 Science and Education Publishing

Cite this paper:
Juan Sebastian Lasa. Complete Resolution of Type 1 Refractory Celiac Disease after Combined Treatment with Budesonide and Azathioprine: A Case Report and Literature Review. International Journal of Celiac Disease. 2015; 3(1):40-43. doi: 10.12691/ijcd-3-1-3.

Correspondence to: Juan  Sebastian Lasa, Gastroenterology Section, Internal Medicine Department, Centro de Educación Médica e Investigación Clínica (CEMIC), Buenos Aires, Argentina. Email: drjuanslasa@gmail.com

Abstract

Refractory Celiac Disease is a rare condition associated with a substancial mortality rate. Both treatment and follow-up are still matter of debate. The case of a 54 year-old man with refractory celiac disease is presented who required treatment with both budesonide and azathioprine. A concise review of the clinical Management of Refractory Celiac Disease is then performed.

Keywords